Patents

US 9255068 B2: Crystalline salts of (4S,4AS,5AR,12AS)-4-dimethylamino-3,10,12,12A-tetrahydroxy-7-[methoxy(methyl)amino)-methyl] acid amide and methods of using the same

Granted
2016-02-09
Filed
2012-05-14 application 13471275
Type
Utility · 72 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A crystalline mono hydrochloride salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide is disclosed having improved stability. In addition, a crystalline mono mesylate salt and crystalline mono sulfate salt of (4S,4aS,5aR,12aS)-4-dimethylamino-3,10,12,12a-tetrahydroxy-7-[(methoxy(methyl)amino)-methyl]-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydro-naphthacene-2-carboxylic acid amide are also disclosed having improved stability. A pharmaceutical composition containing the crystalline salts and methods of treating inflammatory skin disorders and bacterial infections comprising administering the crystalline salts are also disclosed.

Source: PVGPATDIS, file of 2026-04-10 (ipg160209.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
Warner Chilcott Company, LLC 27 patentsUS company or organizationFajardo, PRWARNER CHILCOTT COMPANY, LLC State business registration EXACT high confidence: identical full name and state
WARNER CHILCOTT PLC SEC filer FUZZY low confidence: same name (legal endings aside), one of each nationally
PVGPATDIS, file of 2026-04-10
Paratek Pharmaceuticals, Inc. 41 patentsUS company or organizationBoston, MAPARATEK PHARMACEUTICALS INC Form D issuer EXACT high confidence: identical full name and state
PARATEK PHARMACEUTICALS, INC. SEC filer EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Catherine CoulterBallymena, GB3PVGPATDIS, file of 2026-04-10
Sean M. JohnstonDoylestown, PA10PVGPATDIS, file of 2026-04-10
Farzaneh SeyediMansfield, MA7PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
C07CAcyclic or carbocyclic compoundsC07C237/26PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P17/00PVGPATDIS, file of 2026-04-10
C07BGeneral methods of organic chemistry; apparatus thereforC07B2200/07PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2026-03-17Release of security interest
Release of security interest in patents recorded at reel/frame 71200/0656
OAKTREE FUND ADMINISTRATION, LLC signed 2026-03-16PARATEK PHARMACEUTICALS, INC. CAMBRIDGE, MA75101/815PASDL, file of 2026-10-15
2026-03-16Security interest Security interest
Patent security agreement
PARATEK PHARMACEUTICALS, INC. signed 2026-03-16WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT MINNEAPOLIS, MN75111/244PASDL, file of 2026-10-15
2025-05-22Release of security interest
Release of security interest in patents recorded at reel/frame 065001/0917
OAKTREE FUND ADMINISTRATION, LLC signed 2025-05-21PARATEK PHARMACEUTICALS, INC. CAMBRIDGE, MA71343/407PASDL, file of 2026-10-15
2025-05-22Security interest Security interest
Security interest
PARATEK PHARMACEUTICALS, INC. signed 2025-05-21OAKTREE FUND ADMINISTRATION, LLC LOS ANGELES, CA71200/656PASDL, file of 2026-10-15
2023-09-22Security interest Security interest
Security interest
PARATEK PHARMACEUTICALS, INC. signed 2023-09-21OAKTREE FUND ADMINISTRATION, LLC LOS ANGELES, CA65001/917PASDL, file of 2026-10-15
2018-02-22Correction
Corrective assignment to correct the us patent no. 8,050,873 previously recorded on reel 040183 frame 0129. assignor(s) hereby confirms the assignment.
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1745417/593PASDL, file of 2026-10-15
2016-09-29Assignment
Assignment of assignor's interest
WARNER CHILCOTT COMPANY, LLC signed 2015-12-31ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED DUBLIN 1740183/129PASDL, file of 2026-10-15
2014-12-23Release of security interest
Termination of lien on patents
MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC signed 2014-12-22PARATEK PHARMACEUTICALS, INC. BOSTON, MA34700/377PASDL, file of 2026-10-15
2014-10-31Release of security interest
Release of security interest
HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT signed 2014-10-31PARATEK PHARMACEUTICALS, INC. BOSTON, MA34113/910PASDL, file of 2026-10-15
2014-03-14Security interest Security interest
Security interest
PARATEK PHARMACEUTICALS, INC. signed 2014-03-07HBM HEALTHCARE INVESTMENTS (CAYMAN) LTD., AS COLLATERAL AGENT ZUG32448/1PASDL, file of 2026-10-15
2013-03-08Missing
Notice
PARATEK PHARMACEUTICALS, INC. signed 2013-03-08MINTZ LEVIN COHN FERRIS GLOVSKY AND POPEO PC BOSTON, MA29940/106PASDL, file of 2026-10-15
2012-09-25Assignment
Assignment of assignor's interest
COULTER, CATHERINE signed 2012-05-21
JOHNSTON, SEAN M. signed 2012-07-25
SEYEDI, FARZANEH signed 2012-07-25
PARATEK PHARMACEUTICALS, INC. BOSTON, MA
WARNER CHILCOTT COMPANY, LLC FAJARDO, PR
29018/831ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.